Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BD Completes GeneOhm buy

This article was originally published in The Gray Sheet

Executive Summary

BD will launch a global initiative to reduce healthcare-associated infections after completing its acquisition of molecular diagnostic firm GeneOhm Sciences (1"The Gray Sheet" Jan. 16, 2006, p. 5). BD announced Jan. 10 that it would pay $230 mil., plus up to $25 mil. in milestone payments, to acquire the firm. Assays currently available from GeneOhm include the IDI-Strep B assay for detecting Group B Strep, and IDI-MRSA for detecting methicillin-resistant Staphylococcus aureus. BD has speculated that the market could be worth more than $500 mil...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT023226

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel